Skip to content

Azenta AZTA Liabilities held for sale

Liabilities held for sale at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-16.3%
Enterprise value$1.03B
P/S1.8×-0.2×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's liabilities held for sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's liabilities held for sale?
Azenta (AZTA) reported liabilities held for sale of $31.42M in Q1 2026.
What is the long-term trend for Azenta's liabilities held for sale?
Over 2 years (2020 to 2025), Azenta's liabilities held for sale has grown at a -41.6% compound annual growth rate (CAGR), from $82.83M to $28.27M.
What does liabilities held for sale mean?
Liabilities associated with disposal groups classified as held for sale, presented separately on the balance sheet.